In a prostate cancer cell line, PC3, the levels of anti-apoptotic signaling proteins Bcl-2, Bcl-xL, and survivin were decreased in response to the NF-κB inhibitor genistein. The gene discussed is NFKB1; the disease is prostate carcinoma.